Cemalettin Aybay

582 total citations
36 papers, 486 citations indexed

About

Cemalettin Aybay is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Cemalettin Aybay has authored 36 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Cemalettin Aybay's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Diphtheria, Corynebacterium, and Tetanus (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Cemalettin Aybay is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Diphtheria, Corynebacterium, and Tetanus (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Cemalettin Aybay collaborates with scholars based in Türkiye, Belgium and Austria. Cemalettin Aybay's co-authors include Turgut İmir, Hamza Okur, Alev Hasanoğlu, Mehmet Ali Gürer, Leyla Tümer, Esra Adışen, Ayşegül Atak Yücel, Sumru Özel, Mehmet Gündüz and Kayhan Çağlar and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and Journal of Immunological Methods.

In The Last Decade

Cemalettin Aybay

35 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cemalettin Aybay Türkiye 14 124 109 76 69 58 36 486
M Hvatum Norway 13 92 0.7× 91 0.8× 53 0.7× 63 0.9× 105 1.8× 20 482
Andrew R. Freedman United Kingdom 14 110 0.9× 102 0.9× 94 1.2× 122 1.8× 79 1.4× 24 627
Diego Saita Italy 10 147 1.2× 90 0.8× 302 4.0× 85 1.2× 46 0.8× 12 600
Aysen Samstag Austria 9 71 0.6× 210 1.9× 65 0.9× 59 0.9× 23 0.4× 11 427
Emer Lawlor Ireland 16 326 2.6× 252 2.3× 68 0.9× 27 0.4× 35 0.6× 31 826
J.W.M. Lawton Hong Kong 16 160 1.3× 221 2.0× 81 1.1× 45 0.7× 21 0.4× 54 692
Alessia Grassi Italy 12 107 0.9× 148 1.4× 188 2.5× 103 1.5× 24 0.4× 20 623
Z T Handzel Israel 14 172 1.4× 186 1.7× 74 1.0× 31 0.4× 51 0.9× 31 498
Noora Alakulppi Finland 12 152 1.2× 152 1.4× 250 3.3× 149 2.2× 74 1.3× 19 675
William Otero Colombia 13 68 0.5× 195 1.8× 89 1.2× 382 5.5× 102 1.8× 61 727

Countries citing papers authored by Cemalettin Aybay

Since Specialization
Citations

This map shows the geographic impact of Cemalettin Aybay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cemalettin Aybay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cemalettin Aybay more than expected).

Fields of papers citing papers by Cemalettin Aybay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cemalettin Aybay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cemalettin Aybay. The network helps show where Cemalettin Aybay may publish in the future.

Co-authorship network of co-authors of Cemalettin Aybay

This figure shows the co-authorship network connecting the top 25 collaborators of Cemalettin Aybay. A scholar is included among the top collaborators of Cemalettin Aybay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cemalettin Aybay. Cemalettin Aybay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derici, Ülver, Cemalettin Aybay, Gülten Taçoy, et al.. (2009). The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. Journal of Nephrology. 22(2). 216–223. 21 indexed citations
2.
Aybay, Cemalettin, et al.. (2008). Salivary Epidermal Growth Factor Levels in Behçet’s Disease and Recurrent Aphthous Stomatitis. Dermatology. 217(3). 235–240. 20 indexed citations
3.
Çevik, Müge, Ufuk Beyazova, Aysu Duyan Çamurdan, et al.. (2008). Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey. Clinical Microbiology and Infection. 14(4). 388–390. 16 indexed citations
4.
Yücel, Ayşegül Atak, et al.. (2007). Investigation of the functional characteristics of antibodies to therapeutic anti-human tumor necrosis factor alpha monoclonal antibody. Immunology Letters. 111(2). 84–91. 1 indexed citations
5.
Baştürk, Bilkay, et al.. (2007). Development of a Highly Sensitive ELISA for Quantification of Hepatitis B Virus (HBV) Surface Antigen (HBsAg). TURKISH JOURNAL OF MEDICAL SCIENCES. 37(2). 87–92. 5 indexed citations
6.
Hızel, Kenan, et al.. (2007). Determinants of Protection Against Diphtheria in Adult Hemodialysis Patients. Renal Failure. 29(7). 829–834. 3 indexed citations
7.
Dursun, Hasan, Peyamı Cınaz, Aysun Bıdecı, et al.. (2007). Serum levels of sL-selectin and tumour necrosis factor-α in children with type 1 diabetes mellitus. Acta Diabetologica. 44(1). 1–5. 5 indexed citations
8.
Çağlar, Kayhan, et al.. (2007). Evaluation of human antibody responses to diphtheria toxin subunits A and B in various age groups. Clinical Microbiology and Infection. 13(11). 1065–1071. 3 indexed citations
9.
Yücel, Ayşegül Atak, et al.. (2006). Effect of Blood Collection Tube Types on the Measurement of Human Epidermal Growth Factor. Journal of Immunoassay and Immunochemistry. 28(1). 47–60. 9 indexed citations
10.
Aybay, Cemalettin, et al.. (2006). Characterization of human epidermal growth factor in human serum and urine under native conditions. Cytokine. 35(1-2). 36–43. 11 indexed citations
11.
Yücel, Ayşegül Atak & Cemalettin Aybay. (2005). Development of ELISA Systems for Measurement of Human Tumor Necrosis Factor-Alpha (TNF-\alpha). TURKISH JOURNAL OF MEDICAL SCIENCES. 35(6). 385–393. 2 indexed citations
12.
Aybay, Cemalettin. (2004). Development of an Enzyme‐Linked Immunoassay for Sensitive Detection of Native and Recombinant Human Interferon‐γ Using Whole IgG Fraction as Polyclonal Tracer. Journal of Immunoassay and Immunochemistry. 25(4). 321–334. 1 indexed citations
13.
Aybay, Cemalettin, et al.. (2003). Development of a Diagnostic and Screening Elisa System for Measuring Tetanus Antitoxoid Levels. TURKISH JOURNAL OF MEDICAL SCIENCES. 33(5). 289–294. 2 indexed citations
14.
Aybay, Cemalettin. (2003). Measurement of Urine Albumin Levels With A Monoclonal Antibody Based in-House Elisa. TURKISH JOURNAL OF MEDICAL SCIENCES. 33(1). 1–5. 9 indexed citations
15.
Aybay, Cemalettin. (2003). Differential binding characteristics of protein G and protein A for Fc fragments of papain-digested mouse IgG. Immunology Letters. 85(3). 231–235. 31 indexed citations
16.
Tanyüksel, Mehmet, Ahmet Levent Baş, Engin Araz, & Cemalettin Aybay. (2002). Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro. Cell Biochemistry and Function. 21(1). 93–96. 13 indexed citations
17.
Tümer, Leyla, Alev Hasanoğlu, & Cemalettin Aybay. (2001). Endomysium antibodies in the diagnosis of celiac disease in short‐statured children with no gastrointestinal symptoms. Pediatrics International. 43(1). 71–73. 35 indexed citations
18.
19.
Aybay, Cemalettin & Turgut İmir. (1996). Tumor Necrosis Factor (TNF) Induction from Monocyte/Macrophages by Candida Species. Immunobiology. 196(4). 363–374. 24 indexed citations
20.
Aybay, Cemalettin, Turgut İmir, & Hamza Okur. (1995). The effect of omeprazole on human natural killer cell activity. General Pharmacology The Vascular System. 26(6). 1413–1418. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Hvatum Breakdown of academic impact, for papers by Andrew R. Freedman Breakdown of academic impact, for papers by Diego Saita Breakdown of academic impact, for papers by Aysen Samstag Breakdown of academic impact, for papers by Emer Lawlor Breakdown of academic impact, for papers by J.W.M. Lawton Breakdown of academic impact, for papers by Alessia Grassi Breakdown of academic impact, for papers by Z T Handzel Breakdown of academic impact, for papers by Noora Alakulppi Breakdown of academic impact, for papers by William Otero
Rankless by CCL
2026